Product How it works Pricing Blog FAQ About Contact
Melrose Industries

Melrose Industries (LON: MRO) financial statements

The consolidated income statement, balance sheet and cash flow statement of Melrose Industries for its last 5 fiscal years, as filed with the regulator, in millions of pounds. At the end of fiscal 2025 it had £7,596m in total assets and £2,827m in equity.

Income statement

Item20252024202320222021
Revenue£3,589m£3,468m£3,350m£7,537m£6,650m
Cost of sales£2,635m£2,646m£2,696m£6,458m£5,750m
Gross profit£954.0m£822.0m£654.0m£1,079m£900.0m
Operating profit£600.0m−£4.0m£57.0m−£236.0m−£493.0m
Finance costs£132.0m£105.0m£79.0m£104.0m£169.0m
Profit before tax£468.0m−£106.0m−£8.0m−£307.0m−£660.0m
Income tax£98.0m−£57.0m−£9.0m−£84.0m−£180.0m
Net profit£370.0m−£49.0m−£1,019m−£308.0m£833.0m
Earnings per share£0.29−£0.037—−£0.054—
Diluted earnings per share£0.29−£0.037—−£0.054—

Balance sheet

Item20252024202320222021
Total assets£7,596m£7,436m£6,929m£13,987m£14,022m
Current assets£1,709m£1,580m£1,318m£2,873m£2,584m
Inventories£542.0m£528.0m£510.0m£1,025m£893.0m
Property, plant and equipment£864.0m£821.0m£777.0m£2,599m£2,528m
Cash£166.0m£88.0m£58.0m£355.0m£473.0m
Total liabilities£4,769m£4,592m£3,362m£6,819m£6,482m
Current liabilities£1,737m£1,751m£1,533m£2,978m£3,124m
Equity£2,827m£2,844m£3,567m£7,129m£7,507m
Equity including minorities£2,827m£2,844m£3,567m£7,168m£7,540m
Minority interests—£0.0m£0.0m£39.0m£33.0m

Cash flow statement

Item20252024202320222021
Operating cash flow£214.0m−£121.0m£29.0m£204.0m£263.0m
Investing cash flow−£82.0m−£68.0m£721.0m£192.0m£2,511m
Financing cash flow−£58.0m£219.0m−£966.0m−£599.0m−£2,466m
Capital expenditure£86.0m£108.0m£95.0m£271.0m£218.0m

Where each figure comes from

From the annual report Melrose Industries files every year in the European single electronic format (ESEF). The filing for each fiscal year: 2025 · 2023 · 2022. If an item is not tagged in the filing, it is not in the table. The summary of the last fiscal year is on the Melrose Industries page.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.